Allergic reactions

Allergy is a broad subject that covers a range of diseases. In general terms, an allergy is an immune reaction to an environmental substance that would not provoke a reaction

...


Read more on Allergic reactions

 

 

Latest news articles

Added 1 month ago Drug news

Positive results for ligelizumab to treat chronic spontaneous urticaria.- Novartis

Results from a Phase IIb dose-finding study show an average complete response rate of 42% for doses 240 mg and...

Added 1 month ago Drug news

Adamis Pharmaceuticals announces commercial partnership with Emerge Health for Symjepi in Australia and New Zealand.

Adamis Pharmaceuticals Corporation announced that it has entered into an exclusive distribution and commercialization agreement with Emerge Health Pty to...

Added 2 months ago Drug news

FDA Allergenic Products Advisory Committee votes to support the use of Palforzia (AR101) for peanut allergy.- Aimmune Therapeutics Inc.

Aimmune Therapeutics, Inc. announced that the Allergenic Products Advisory Committee (APAC) convened by the FDA voted to support the use...

Search all news articles for Allergic reactions
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

EADV 2018 Highlights

EADV 2018 Highlights

EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.

Allergic Rhinitis

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

+ 4 more

Load more

Guidelines

British Association of Dermatologists’ guidelines for the management of contact dermatitis 2017

The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of contact dermatitis.

Added 10 years ago

BSACI guideline for the management of chronic urticaria and angioedema

This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI).

Added 4 years ago

Management of allergy to penicillins and other beta-lactams

The Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI) and an expert panel have prepared this guidance for the management of immediate and non-immediate allergic reactions to penicillin...

Added 4 years ago

Search all guidelines for Allergic reactions
 

Journal articles

Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications.

Chronic urticaria (CU) is a mast cell-driven disease characterized by the development of wheals, angioedema, or both for more than 6 weeks. The two major sub-types are chronic spontaneous urticaria (CSU) and inducible urticaria.

Added 19 days ago

Ligelizumab for Chronic Spontaneous Urticaria.

Background: In the majority of patients with chronic spontaneous urticaria, most currently available therapies do not result in complete symptom control. Ligelizumab is a next-generation high-affinity humanized monoclonal...

Added 19 days ago

Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis.

Introduction: Chronic spontaneous urticaria (CSU) affects approximately 1% of the population, affecting both children and adults. Omalizumab (Oma) is a therapeutic option for patients with refractory forms of CSU.

Added 19 days ago

Search all journal articles for Allergic reactions
 

Clinical trials

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description

Added 19 days ago

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE 2)

This is a multi-center, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.

Added 19 days ago

Open-label, Multicenter, Extension Study to Evaluate Long-term Safety and Tolerability of LOU064 in Subjects With CSU

This study is an open-label, single arm, multicenter, long-term safety and tolerability extension study for CSU patients who completed CLOU064A2201 or other preceding studies with LOU064

Added 19 days ago

Search all clinical trials for Allergic reactions
 
Lauren McCracken

Lauren McCracken works for our sister agency Digital Medical Communications (DMC Ltd) as an Associate Medical Writer. Lauren is very passionate about healthcare and how technology can improve treatments, and has written a blog series 'Transforming lives through technology'

... Read more

EAACI hot topics: Hereditary angioedema (HAE)

For many the fear of the unknown is a daunting thought, but particularly so for patients with HAE. Left untreated, this disease causes unpredictable recurrent severe swelling, typically of the limbs, face, intestinal tract and airway.

CME

EAACI 2017: The future of urticaria – advances in CSU research

EAACI 2017: The future of urticaria – advances in CSU research
Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE

Chronic Spontaneous Urticaria Case Consults: Changing Paradigms in the Age of Biologics

Chronic Spontaneous Urticaria Case Consults: Changing Paradigms in the Age of Biologics
Accrediting body
Credits available
0
Registration required
1
Subscription fee
FREE

Managing CSU and its comorbidities: from primary to secondary care

Managing CSU and its comorbidities: from primary to secondary care
Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
FREE
Search all CME for Allergic reactions